Patent Yard Sign in
Canadian application, no grantCanada

Compositions for the treatment of chronic wounds

CA 2225202 A1 · Owner: Johnson & Johnson Medical Ltd. · Inventors: Bloor, Stephen

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides the use of N-acetyl cysteine and its pharmaceutically acceptable salts and derivatives, for the preparation of a composition for treatment or prophylaxis of chronic ulcers. In particular the treatment of venous ulcers, diabetic ulcers and decubitis ulcers.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 18, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 18, 1997
GrantedNo grant recorded
Term endedDecember 18, 2017
Patent numberCA 2225202 A1
Classification (IPC)A61K31/19 +1 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedDec 18, 1997Term endedDec 18, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.